Loading…
Hangzhou Huiji Biotechnology Co., Ltd., an OTC drug manufacturer, violated Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals, rendering their products adulterated. The company failed to conduct required identity testing on incoming drug components prior to use in manufacturing, including ethyl alcohol used in gel hand sanitizers, and did not demonstrate adequate verification of raw materials across shipments. These violations of 21 CFR 211.84(d)(1) indicated that the firm's methods, facilities, and controls for manufacturing, processing, and holding drugs did not conform to CGMP standards.